Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ORPH

Orphazyme A/S (ORPH) Stock Price, News & Analysis

Orphazyme A/S logo

About Orphazyme A/S Stock (NASDAQ:ORPH)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.57
$2.21
52-Week Range
N/A
Volume
941,400 shs
Average Volume
1.37 million shs
Market Capitalization
$30.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ORPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orphazyme A/S and its competitors with MarketBeat's FREE daily newsletter.

ORPH Stock News Headlines

Gold is soaring. Here’s how to get paid from it
Gold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork.
See More Headlines

ORPH Stock Analysis - Frequently Asked Questions

Orphazyme A/S (ORPH) raised $100 million in an initial public offering on Tuesday, September 29th 2020. The company issued 7,600,000 shares at $13.13 per share. BofA Securities, Cowen and Guggenheim Securities served as the underwriters for the IPO and Danske Markets was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Orphazyme A/S investors own include AMC Entertainment (AMC), Digital World Acquisition (DWAC), NIO (NIO), Biora Therapeutics (BIOR), SNDL (SNDL), Tesla (TSLA) and Brigham Minerals (MNRL).

Company Calendar

Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ORPH
CIK
1764791
Fax
N/A
Employees
141
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.14
Current Ratio
1.80
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.74 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
35,312,000
Free Float
N/A
Market Cap
$30.72 million
Optionable
Not Optionable
Beta
1.68
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:ORPH) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners